Literature DB >> 11988579

Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells.

Anura Rambukkana1, George Zanazzi, Nikos Tapinos, James L Salzer.   

Abstract

Demyelination results in severe disability in many neurodegenerative diseases and nervous system infections, and it is typically mediated by inflammatory responses. Mycobacterium leprae, the causative organism of leprosy, induced rapid demyelination by a contact-dependent mechanism in the absence of immune cells in an in vitro nerve tissue culture model and in Rag1-knockout (Rag1-/-) mice, which lack mature B and T lymphocytes. Myelinated Schwann cells were resistant to M. leprae invasion but undergo demyelination upon bacterial attachment, whereas nonmyelinated Schwann cells harbor intracellular M. leprae in large numbers. During M. leprae-induced demyelination, Schwann cells proliferate significantly both in vitro and in vivo and generate a more nonmyelinated phenotype, thereby securing the intracellular niche for M. leprae.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988579     DOI: 10.1126/science.1067631

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  46 in total

1.  In vivo coherent anti-Stokes Raman scattering imaging of sciatic nerve tissue.

Authors:  T B Huff; J-X Cheng
Journal:  J Microsc       Date:  2007-02       Impact factor: 1.758

2.  Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli.

Authors:  Nikos Tapinos; Anura Rambukkana
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

Review 3.  Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.

Authors:  Roberta Olmo Pinheiro; Jorgenilce de Souza Salles; Euzenir Nunes Sarno; Elizabeth Pereira Sampaio
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

4.  Biosynthesis of cell envelope-associated phenolic glycolipids in Mycobacterium marinum.

Authors:  Olivia Vergnolle; Sivagami Sundaram Chavadi; Uthamaphani R Edupuganti; Poornima Mohandas; Catherine Chan; Julie Zeng; Mykhailo Kopylov; Nicholas G Angelo; J David Warren; Clifford E Soll; Luis E N Quadri
Journal:  J Bacteriol       Date:  2015-01-05       Impact factor: 3.490

5.  Analysis of Mycobacterium species for the presence of a macrolide toxin, mycolactone.

Authors:  Alexa K Daniel; Richard E Lee; Francoise Portaels; P L C Small
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Mycobacterial polyketide-associated proteins are acyltransferases: proof of principle with Mycobacterium tuberculosis PapA5.

Authors:  Kenolisa C Onwueme; Julian A Ferreras; John Buglino; Christopher D Lima; Luis E N Quadri
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-18       Impact factor: 11.205

7.  Targeting Schwann cells by nonlytic arenaviral infection selectively inhibits myelination.

Authors:  Anura Rambukkana; Stefan Kunz; Jenny Min; Kevin P Campbell; Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

8.  Mycobacterial phenolic glycolipid virulence factor biosynthesis: mechanism and small-molecule inhibition of polyketide chain initiation.

Authors:  Julian A Ferreras; Karen L Stirrett; Xuequan Lu; Jae-Sang Ryu; Clifford E Soll; Derek S Tan; Luis E N Quadri
Journal:  Chem Biol       Date:  2007-12-27

Review 9.  Biological role of dystroglycan in Schwann cell function and its implications in peripheral nervous system diseases.

Authors:  Toshihiro Masaki; Kiichiro Matsumura
Journal:  J Biomed Biotechnol       Date:  2010-06-15

10.  Cooperation between a coenzyme A-independent stand-alone initiation module and an iterative type I polyketide synthase during synthesis of mycobacterial phenolic glycolipids.

Authors:  Weiguo He; Clifford E Soll; Sivagami Sundaram Chavadi; Guangtao Zhang; J David Warren; Luis E N Quadri
Journal:  J Am Chem Soc       Date:  2009-11-25       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.